Energy Balance Pathways: Studying integrated metabolic response mechanisms
Sahni N, McGrail DJ, Garnett J, Yin J, Dai H, H Shih DJ, Peng G, Menter D, Yates MS, Kopetz S , Lu K, Broaddus R, Mills GB, Lin SY
OmoleJGAyokaOAAlabiQKAdefisayoMAAsafaMAOlubunmiBOet alProtective effect of kolaviron on cyclophosphamide-induced cardiac toxicity in rats
Early weight loss responders to liraglutide 3.0 mg achieved greater weight loss and regression to normoglycaemia, and reduced development of T2D at 3 years, versus early nonresponders in the SCALE obesity and prediabetes trial [abstract]
Like other GLP-1 based medications, stopping treatment can lead to a return of appetite and some weight regain if no other supports are in place